The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats

Behavioural Pharmacology

Volumn 23, Issue 2, 2012, Pages 191-197

  Milić, Marija ^a   Divljaković, Jovana ^a   Rallapalli, Sundari ^b   Van Linn, Michael L ^b   Timić, Tamara ^a   Cook, James M ^b   Savić, Miroslav M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

ataxia; grip strength; muscle relaxation; rat; rotarod

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID, 8 ETHYNYL 5,6 DIHYDRO 5 METHYL 6 OXO, 1,3 PROPANEDIYL ESTER); BENZODIAZEPINE; BETA CARBOLINE 3 CARBOXYLIC ACID TERT BUTYL ESTER; DIAZEPAM; ESTER DERIVATIVE; FLUMAZENIL; UNCLASSIFIED DRUG; ZOLPIDEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; CONTROLLED STUDY; DRUG MEGADOSE; GRIP STRENGTH; MALE; MOTOR DYSFUNCTION; MUSCLE RELAXATION; NONHUMAN; RAT; ROTAROD TEST;

ANIMALS; ATAXIA; BENZODIAZEPINES; BENZODIAZEPINONES; CARBOLINES; DIAZEPAM; FLUMAZENIL; GABA-A RECEPTOR AGONISTS; GABA-A RECEPTOR ANTAGONISTS; HAND STRENGTH; IMIDAZOLES; MALE; MUSCLE RELAXATION; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, GABA-A; ROTAROD PERFORMANCE TEST;

EID: 84858708930     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283512c85     Document Type: Article

References (34)

1. Atack JR (2010). GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics. Curr Top Behav Neurosci 2: 331-360.
2. Atack JR, Smith AJ, Emms F, McKernan RM (1999). Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors. Neuropsychopharmacology 20:255-262. (Pubitemid 29067404)
3. Belzung C, Le Guisquet AM, Griebel G (2000). Beta-CCT, a selective BZomega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice. Behav Pharmacol 11:125-131. (Pubitemid 30315847)
4. Benavides J, Peny B, Durand A, Arbilla S, Scatton B (1992). Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. J Pharmacol Exp Ther 263:884-896.
5. Bohlhalter S, Weinmann O, Mohler H, Fritschy JM (1996). Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci 16:283-297.
6. Cox ED, Hagen TJ, McKernan RM, Cook JM (1995). BZ1 receptor subtype specific ligands. Synthesis and biological properties of beta-CCt, a BZ1 receptor subtype specific antagonist. Med Chem Res 5:710-718.
7. Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, et al. (2002). Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci 22:5572-5580. (Pubitemid 35386478)
8. Crestani F, Löw K, Keist R, Mandelli M, Möhler H, Rudolph U (2001). Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442-445. (Pubitemid 32179921)
9. Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, et al. (2002). Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci USA 99:8980-8985. (Pubitemid 34693669)
10. Elliot EE, White JM (2001). The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry. Neuropharmacology 40:717-721. (Pubitemid 32323995)
11. Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ (1999). New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology (Berl) 146:205-213. (Pubitemid 29474214)
12. Huang Q, He X, Ma C, Liu R, Yu S, Dayer CA, et al. (2000). Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5-beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligandmapping approach. J Med Chem 13:71-95. (Pubitemid 30055764)
13. Li X, Cao H, Zhang C, Furtmueller R, Fuchs K, Huck S, et al. (2003). Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1, 5a]-[1, 4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist. J Med Chem 46:5567-5570. (Pubitemid 37543306)
14. Licata SC, Platt DM, Cook JM, Sarma PV, Griebel G, Rowlett JK (2005). Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4- (pyrrolidin-1-yl-carbonyl)-2, 9-dihydro-1H-pyridol[3, 4-b]indol-1-one]. J Pharmacol Exp Ther 313:1118-1125. (Pubitemid 40727015)
15. Licata SC, Platt DM, Cook JM, van Linn ML, Rowlett JK (2009). Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys. Psychopharmacology (Berl) 203:539-546.
16. Löw K, Crestani F, Keist R, Benke D, BrÜnig I, Benson JA, et al. (2000). Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134.
17. Maurissen JP, Marable BR, Andrus AK, Stebbins KE (2003). Factors affecting grip strength testing. Neurotoxicol Teratol 25:543-553. (Pubitemid 37103052)
18. McKernan RM, Whiting PJ (1996). Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19:139-143.
19. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, et al. (2000). Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 6:587-592. (Pubitemid 30332078)
20. Mirza NR, Larsen JS, Mathiasen C, Jacobsen TA, Munro G, Erichsen HK, et al. (2008). NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]- biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. J Pharmacol Exp Ther 327:954-968.
21. Platt DM, Rowlett JK, Spealman RD, Cook J, Ma C (2002). Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. Psychopharmacology (Berl) 164:151-159. (Pubitemid 36015578)
22. Rowlett JK, Tornatzky W, Cook JM, Ma C, Miczek KA (2001). Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt). J Pharmacol Exp Ther 297:247-253. (Pubitemid 32243489)
23. Rowlett JK, Cook JM, Duke AN, Platt DM (2005). Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. CNS Spectr 10:40-48. (Pubitemid 40139742)
24. Rudolph U, Möhler H (2004). Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics (Review). Annu Rev Pharmacol Toxicol 44: 475-498. (Pubitemid 38263850)
25. Rudolph U, Crestani F, Benke D, BrÜnig I, Benson JA, Fritschy JM, et al. (1999). Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401:796-800.
26. Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, et al. (2002). Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol 451:103-110. (Pubitemid 35253948)
27. SavićMM, ObradovićDI, UgresićND, Cook JM, Yin W, BokonjićDR (2004). Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt. Pharmacol Biochem Behav 79:279-290. (Pubitemid 40029230)
28. SavićMM, ObradovićDI, UgresićND, Cook JM, Sarma PV, BokonjićDR (2005). Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt. Psychopharmacology (Berl) 180:455-465. (Pubitemid 40905035)
29. SavićMM, Huang S, FurtmÜller R, Clayton T, Huck S, ObradovićDI, et al. (2008). Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists? Neuropsychopharmacology 33:332-339. (Pubitemid 350243345)
30. SavićMM, MilinkovićMM, Rallapalli S, Clayton T Sr, JoksimovićS, Van Linn M, Cook JM (2009). The differential role of alpha1-and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. Int J Neuropsychopharmacol 12:1179-1193.
31. Shannon HE, Guzman F, Cook JM (1984). Beta-Carboline-3-carboxylate-t- butyl ester: a selective BZ1 benzodiazepine receptor antagonist. Life Sci 35:2227-2236. (Pubitemid 15202085)
32. Sieghart W (2006). Structure, pharmacology, and function of GABAA receptor subtypes. Adv Pharmacol 54:231-263.
33. Van Rijnsoever C, Täuber M, Choulli MK, Keist R, Rudolph U, Mohler H, et al. (2004). Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24: 6785-6790. (Pubitemid 38993900)
34. Verster JC, Volkerts ER, Verbaten MN (2002). Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study. Neuropsychopharmacology 27:260-269. (Pubitemid 34686976)